BMP-7

• Accession Number:

  P18075

• Expression Region:

  Met316-His431

• Expression System:

  CHO

• Tag:

  Tag free

• Stability:

  36 months at -20°C to -80°C in lyophilized state 6 months at -20°C to -80°C under sterile conditions after reconstitution 7-10 days at 2°C to 8°C under sterile conditions after reconstitution Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

• Endotoxin:

  ≤10 EU/mg

• Purity:

  ≥ 95% as determined by SDS-PAGE

• Activity:

  Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 0.02-0.04 μg/ml.

• Reconstitution:

  It is recommended to redissolve in 4mM HCL

• Molecular Weight:

  13.1 kDa

• Shipping Conditions:

  Blue Ice

• Appearance:

  White powder, Colorless clear liquid after reconstitution

• Formulation:

  Lyophilized from a 0.22 μm-filtered solution containing 0.085% TFA, 30% ACN, 5% mannitol

• Product Name Synonym:

  Bone morphogenetic protein 7; BMP-7; Osteogenic protein 1 (OP-1) ; Eptotermin alfa; BMP7; OP1

• Species:

  Human